Prescription drug monitoring programs (PDMPs) are a key component of the President’s Prescription Drug Abuse Prevention Plan and considered a critical tool for reducing prescription opioid-related illness and death. The results of a new study show there is insufficient evidence to confirm whether implementing these programs actually increases or decreases overdoses.